Appleton Partners’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.43M | Sell |
31,102
-884
| -3% | -$71.3K | 0.15% | 103 |
|
|
2026
Q1 | $2.77M | Sell |
31,986
-214
| -0.7% | -$20.5K | 0.19% | 99 |
|
|
2025
Q4 | $3.09M | Sell |
32,200
-693
| -2% | -$67.3K | 0.2% | 97 |
|
|
2025
Q3 | $3.13M | Buy |
32,893
+91
| +0.3% | +$8.37K | 0.21% | 96 |
|
|
2025
Q2 | $2.86M | Sell |
32,802
-2,092
| -6% | -$177K | 0.2% | 100 |
|
|
2025
Q1 | $3.14M | Buy |
34,894
+1,590
| +5% | +$142K | 0.24% | 89 |
|
|
2024
Q4 | $2.66M | Sell |
33,304
-898
| -3% | -$77.7K | 0.2% | 98 |
|
|
2024
Q3 | $3.08M | Sell |
34,202
-1,665
| -5% | -$140K | 0.23% | 92 |
|
|
2024
Q2 | $2.82M | Sell |
35,867
-1,443
| -4% | -$118K | 0.22% | 91 |
|
|
2024
Q1 | $3.25M | Sell |
37,310
-9,228
| -20% | -$788K | 0.25% | 91 |
|
|
2023
Q4 | $3.83M | Sell |
46,538
-1,596
| -3% | -$122K | 0.31% | 82 |
|
|
2023
Q3 | $3.77M | Sell |
48,134
-970
| -2% | -$81.2K | 0.34% | 78 |
|
|
2023
Q2 | $4.33M | Sell |
49,104
-6,366
| -11% | -$548K | 0.37% | 75 |
|
|
2023
Q1 | $4.47M | Sell |
55,470
-5,581
| -9% | -$455K | 0.4% | 67 |
|
|
2022
Q4 | $4.75M | Sell |
61,051
-15,552
| -20% | -$1.26M | 0.45% | 64 |
|
|
2022
Q3 | $6.19M | Sell |
76,603
-315
| -0.4% | -$28.3K | 0.62% | 43 |
|
|
2022
Q2 | $6.9M | Buy |
76,918
+242
| +0.3% | +$24.5K | 0.65% | 44 |
|
|
2022
Q1 | $8.51M | Sell |
76,676
-1,827
| -2% | -$193K | 0.7% | 41 |
|
|
2021
Q4 | $8.12M | Sell |
78,503
-1,271
| -2% | -$147K | 0.61% | 50 |
|
|
2021
Q3 | $10M | Buy |
79,774
+354
| +0.4% | +$45.8K | 0.83% | 35 |
|
|
2021
Q2 | $9.86M | Sell |
79,420
-826
| -1% | -$104K | 0.84% | 33 |
|
|
2021
Q1 | $9.48M | Sell |
80,246
-1,082
| -1% | -$127K | 0.88% | 32 |
|
|
2020
Q4 | $9.53M | Sell |
81,328
-307
| -0.4% | -$33.8K | 0.94% | 31 |
|
|
2020
Q3 | $8.48M | Buy |
81,635
+593
| +0.7% | +$59.6K | 0.94% | 30 |
|
|
2020
Q2 | $7.43M | Sell |
81,042
-405
| -0.5% | -$38.8K | 0.89% | 30 |
|
|
2020
Q1 | $7.34M | Buy |
81,447
+672
| +0.8% | +$71.5K | 1.02% | 29 |
|
|
2019
Q4 | $9.16M | Buy |
80,775
+1,264
| +2% | +$139K | 1.01% | 29 |
|
|
2019
Q3 | $8.64M | Buy |
79,511
+291
| +0.4% | +$30.4K | 1.04% | 26 |
|
|
2019
Q2 | $7.71M | Buy |
79,220
+1,090
| +1% | +$99.5K | 0.95% | 30 |
|
|
2019
Q1 | $7.12M | Buy |
78,130
+173
| +0.2% | +$15.5K | 0.94% | 30 |
|
|
2018
Q4 | $7.09M | Buy |
77,957
+1,762
| +2% | +$165K | 1.06% | 23 |
|
|
2018
Q3 | $7.5M | Buy |
76,195
+1,084
| +1% | +$100K | 1% | 29 |
|
|
2018
Q2 | $6.43M | Buy |
75,111
+1,462
| +2% | +$122K | 0.92% | 30 |
|
|
2018
Q1 | $5.91M | Buy |
73,649
+555
| +0.8% | +$45.8K | 0.9% | 32 |
|
|
2017
Q4 | $5.9M | Sell |
73,094
-1,911
| -3% | -$153K | 0.92% | 30 |
|
|
2017
Q3 | $5.83M | Sell |
75,005
-5,140
| -6% | -$427K | 0.98% | 28 |
|
|
2017
Q2 | $7.11M | Buy |
80,145
+5,497
| +7% | +$464K | 1.2% | 17 |
|
|
2017
Q1 | $6.01M | Sell |
74,648
-14,337
| -16% | -$1.12M | 1.11% | 23 |
|
|
2016
Q4 | $6.34M | Sell |
88,985
-4,297
| -5% | -$338K | 1.28% | 23 |
|
|
2016
Q3 | $8.06M | Buy |
93,282
+2,906
| +3% | +$253K | 1.52% | 15 |
|
|
2016
Q2 | $7.84M | Buy |
90,376
+561
| +0.6% | +$45.4K | 1.6% | 17 |
|
|
2016
Q1 | $6.74M | Buy |
89,815
+6,402
| +8% | +$482K | 1.33% | 25 |
|
|
2015
Q4 | $6.42M | Buy |
83,413
+16,607
| +25% | +$1.25M | 1.27% | 27 |
|
|
2015
Q3 | $4.47M | Buy |
66,806
+11,130
| +20% | +$820K | 1.02% | 34 |
|
|
2015
Q2 | $4.13M | Buy |
55,676
+8,532
| +18% | +$652K | 0.92% | 38 |
|
|
2015
Q1 | $3.68M | Buy |
47,144
+39,926
| +553% | +$3.03M | 0.83% | 43 |
|
|
2014
Q4 | $521K | Buy |
7,218
+3,211
| +80% | +$223K | 0.12% | 117 |
|
|
2014
Q3 | $248K | Buy |
4,007
+600
| +18% | +$38.1K | 0.06% | 162 |
|
|
2014
Q2 | $217K | Buy |
+3,407
| New | +$207K | 0.05% | 168 |
|
Other funds holding MDT
FWIA
GAM
SRIM
DC
Appleton Partners's MDT Position: Q2 2026 in Review
Appleton Partners reduced its Medtronic (MDT) stake by 2.8% in Q2 2026, selling an estimated $71.3K and leaving 31,102 shares worth $2.43M. The position accounts for 0.15% of the portfolio, ranked #103.
Appleton Partners first reported a position in MDT in Q2 2014 and has held it in 49 quarters since. The position peaked at $10M in Q3 2021. 961 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Appleton Partners held 31,102 shares of Medtronic worth $2.43M as of Q2 2026.
- Appleton Partners sold 884 Medtronic shares in Q2 2026, an estimated $71.3K.
- Medtronic made up 0.15% of Appleton Partners's portfolio in Q2 2026, its #103 holding.
- Appleton Partners first reported a position in Medtronic in Q2 2014 and has held it in 49 quarters since.
- Appleton Partners's Medtronic position peaked at $10M in Q3 2021.
- 961 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Appleton Partners's 13F filing for Q2 2026, filed 21 Jul 2026.